Moderate riskFDA DrugClass II

Imprimis Dexamethasone Moxifloxacin eye injection recalled for glass-like particles

Imprimis NJOF, LLC is recalling specific lots of Dexamethasone Moxifloxacin intraocular injection due to the presence of glass-like particles in the medication. This injection is used during eye surgery. Two affected lots have been identified and distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have received this injection or your eye surgery is scheduled, contact your ophthalmologist or surgical facility immediately
  2. Do not use affected lots 25MAY051 or 25AUG003
  3. Ask your healthcare provider whether your procedure used medication from these lots

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
778 boxes of 15,540 pre-filled syringes
Illnesses reported
None reported
Manufactured in
1705 Route 46 Ste 6B, Ledgewood, NJ, United States
Classification
Class II
Recall number
D-0249-2026

In the FDA's words

Description
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1 Presence of particulate matter - Glass like particles. Lot: 25MAY051, Expires: 06/26/2026; 25AUG003, Expires:08/07/2026 Distribution: U.S Nationwide Affected quantity: 778 boxes of 15,540 pre-filled syringes
Hazard
Presence of particulate matter - Glass like particles.

3 products in this recall

Imprimis Dexamethasone-Moxifloxacin and Tri-Moxi+ recalled for glass particles

Imprimis is recalling three prefilled eye injection products because they may contain glass-like particles. The products are Dexamethasone Moxifloxacin, Dexamethasone Moxifloxacin Ketorolac, and Tri-Moxi+, with 1,688 affected boxes shipped nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

ParticulateDrugsSold nationwideMore from FDA Drug